Zheng et al. confirmed that levels of CD80, Treg, FOXP3, and mature DCs were significantly lower, and levels of CCR6, Th17 cells, IL-17A, and immature DCs were higher in COPD+ patients than in CS+ COPD− patients and HCs. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.